Multi‑omics identification of a signature based on malignant cell-associated ligand–receptor genes for lung adenocarcinoma

Shengshan Xu(Jiangmen Central Hospital), Zhuming Lu(Jiangmen Central Hospital), Youbin Zheng(Jiangmen Wuyi Traditional Chinese Medicine Hospital), Tao Shen(Jiangmen Central Hospital), Zumei Li(Jiangmen Central Hospital), Yongwen Ke(Jiangmen Central Hospital), Xiguang Chen(First Affiliated Hospital of University of South China), J Chen(Jiangmen Central Hospital), Dongxi Zhang(Jiangmen Central Hospital), Zhuowen Chen(Jiangmen Central Hospital), Xin Zhang(Chinese National Human Genome Center), Haoxuan Ying(Zhujiang Hospital), Min Ye(Jiangmen Central Hospital), Zhichao Lin(Jiangmen Central Hospital)
BMC Cancer
September 12, 2024
10.1186/s12885-024-12911-5
Cited by 36

Related Papers

Metformin Is Associated with Higher Incidence of Acidosis, but Not Mortality, in Individuals with COVID-19 and Pre-existing Type 2 Diabetes
|Cell Metabolism|2020|167
Kidney Function Indicators Predict Adverse Outcomes of COVID-19
|Med|2020|124
Progranulin mediates immune evasion of pancreatic ductal adenocarcinoma through regulation of MHCI expression
|Nature Communications|2022|94
Phospholipid Phosphatase 4 promotes proliferation and tumorigenesis, and activates Ca2+-permeable Cationic Channel in lung carcinoma cells
|Molecular Cancer|2017|67
Clinical application of targeted next-generation sequencing in severe pneumonia: a retrospective review
|Critical Care|2024|64